CPRX vs CYTK
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Aug 02, 2026
CPRX
CYTK
Investment Advisor Scores
CYTK
AI Analyst Insights
Detailed Metrics Comparison
| Metric | CPRX | CYTK | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 12.9534 | 117.6471 | CPRX |
| PEG Ratio | 0 | -0.42 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 5.6% | 1125.8% | CYTK |
| Earnings Growth | 11.1% | 0.0% | CPRX |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 58.5/100 | 59.7/100 | CYTK |
| Profit Margin | 37.1% | 0.0% | CPRX |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | HOLD | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
CPRX
MarkupPrice above SMA50, rising 50-day trend (6.9% over 20 days), RSI 71
CYTK
NeutralMixed signals - no dominant trend phase, RSI 41
Fundamentals Snapshot
| Metric | CPRX | CYTK |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 9.9 | -16.5 |
| Trailing P/E | 18.2 | — |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.1% | 11.3% |
| Gross Margin | 0.8% | -2.9% |
| Operating Margin | 0.5% | -9.5% |
| EPS | 1.73 | -7.03 |
| Dividend Yield | — | — |